Our Pipeline

Science & Pipeline

Hematology

Hematology REBLOZYL^® (luspatercept-aamt)
	Phase 1Ph1	Phase 2Ph2	Phase 3Ph3	ApprovedApp
	REBLOZYL^® (luspatercept-aamt) Beta-Thalassemia
Beta-Thalassemia
	Myelodysplastic Syndromes
Myelodysplastic Syndromes

luspatercept-aamt

luspatercept-aamt
luspatercept-aamt
	Beta-Thalassemia non-transfusion dependent
Beta-Thalassemia non-transfusion dependent	BEYOND TrialBEYOND TrialBEYOND*
	Myelodysplastic Syndromes
Myelodysplastic Syndromes	COMMANDS TrialCOMMANDS TrialCOMMANDS*
	Myelofibrosis
Myelofibrosis	INDEPENDENCE Trial (planned)INDEPENDENCE Trial (planned)INDEP*

Pulmonary

Sotatercept

	Phase 1Ph1	Phase 2Ph2	Phase 3Ph3	ApprovedApp
Pulmonary Sotatercept
Pulmonary Arterial Hypertension
Pulmonary Arterial Hypertension	STELLAR Trial (planned)STELLAR Trial (planned)STELLAR PULSAR TrialPULSAR TrialPULSAR SPECTRA TrialSPECTRASPECTRA HYPERION Trial (planned)HYPERION Trial (planned)HYPERION ZENITH Trial (planned)ZENITH Trial (planned)ZENITH
ACE-1334
Pulmonary Disease
Pulmonary Disease

* Bristol Myers Squibb-sponsored